Compare Natl. Oxygen with Similar Stocks
Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -6.40% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.95
The company has declared Negative results for the last 5 consecutive quarters
Risky - Negative EBITDA
Reducing Promoter Confidence
Below par performance in long term as well as near term
Stock DNA
Other Chemical products
INR 42 Cr (Micro Cap)
NA (Loss Making)
24
0.00%
-8.71
249.65%
-15.05
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-18-2013
Risk Adjusted Returns v/s 
Returns Beta
News

National Oxygen Ltd is Rated Strong Sell
National Oxygen Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 06 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAre National Oxygen Ltd latest results good or bad?
National Oxygen Ltd's latest financial results for Q3 FY26 indicate a company facing significant operational challenges. The reported net sales of ₹5.04 crores reflect a sequential decline of 20.88% from the previous quarter and a year-on-year contraction of 53.25%. This marks the fourth consecutive quarter of declining sales, suggesting persistent demand issues rather than temporary fluctuations. The company reported a net profit of negative ₹1.55 crores, which represents a widening loss compared to a profit of ₹7.04 crores in the prior quarter. This deterioration in profitability is further underscored by an operating margin of negative 14.68%, indicating that the company is struggling to manage its costs effectively in light of declining revenues. National Oxygen's operational efficiency, as indicated by its full-capacity utilization at its plants, has not translated into financial stability. The balan...
Read full news article
National Oxygen Q3 FY26: Losses Deepen Amid Revenue Collapse
National Oxygen Ltd. reported a widening quarterly loss of ₹1.55 crores in Q3 FY26, representing a sharp deterioration from the ₹7.04 crores profit posted in Q2 FY26, as the industrial gases manufacturer grapples with a severe revenue downturn. The micro-cap company, with a market capitalisation of ₹45.00 crores, saw net sales plummet 20.88% quarter-on-quarter to ₹5.04 crores—the lowest quarterly revenue in recent history—whilst year-on-year sales declined by a staggering 53.25%.
Read full news article Announcements 
Financial Results For The Quarter Ended 31St December 2025
30-Jan-2026 | Source : BSESubmission of unaudited results for the quarter ended 31st December 2025
Board Meeting Outcome for For Meeting Held On 30Th January 2026
30-Jan-2026 | Source : BSEThe Unaudited financial results along with the limited review report for the quarter ended 315t December 2025.
Board Meeting Intimation for Meeting To Be Held On 30Th January 2026
27-Jan-2026 | Source : BSENational Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve the unaudited Financial Results of the Company for the quarter ended 31st December 2025.
Corporate Actions 
No Upcoming Board Meetings
National Oxygen Ltd has declared 10% dividend, ex-date: 18 Sep 13
No Splits history available
No Bonus history available
National Oxygen Ltd has announced 3:5 rights issue, ex-date: 26 Jun 12
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Rajesh Kumar Saraf (39.14%)
F L Dadabhoy (5.35%)
28.61%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -20.88% vs -15.96% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -122.02% vs 476.47% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -10.34% vs -3.93% in Mar 2024
YoY Growth in year ended Mar 2025 is -116.72% vs -308.86% in Mar 2024






